News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma – MD Anderson Cancer Center
mdanderson.org
Dec 11, 2024, 09:53

Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma – MD Anderson Cancer Center

MD Anderson Cancer Center shared a post on X:

“For patients with relapsed or refractory large B cell lymphoma and secondary central nervous system involvement, Lisocabtagene Maraleucel (liso-cel) is a feasible and effective option, our Dr. Sairah Ahmed reported at ASH24 this morning.”

Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma - MD Anderson Cancer Center

More posts featuring MD Anderson Cancer Center.

ASH24 cancer Large B-Cell Lymphoma Liso-cel lisocabtagene maraleucel MD Anderson Cancer Center OncoDaily Oncology Sairah Ahmed
Special Coverage
Voices
Aug 21, 2025, 13:39
Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study
Voices
Aug 21, 2025, 13:35
David Skorton: $2 Billion Loss - NIH Funding Crisis Hits Clinical Trials
Insight
Aug 21, 2025, 13:21
Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here
Voices
Aug 21, 2025, 13:19
Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care
Insight
Aug 21, 2025, 13:16
Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment
Voices
Aug 21, 2025, 12:57
How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center
Voices
Aug 21, 2025, 12:34
Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation
Immune Oncology
Aug 21, 2025, 12:34
PPP2R1A Mutations as a Biomarker in Immunotherapy: New Insights from Ovarian Clear Cell Carcinoma
Insight
Aug 21, 2025, 12:31
Alisher Kahharov: Uzbekistan's First National Breast Cancer Guideline - A Collaborative Effort with WHO and Georgian Experts
Radiotherapy
Aug 21, 2025, 12:31
New RT Paper Alert: Novel NOVEMBER Trial Puts 9-Day Breast Cancer Radiation Schedule to the Test
Opinion
Aug 21, 2025, 12:03
UICC Enhances Cancer Care with Nutrition and Psycho-Oncology Support
Voices
Aug 21, 2025, 11:40
FDA has Granted Full Market Approval for Papzimeos - NIH